Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

June 27, 2018June 27, 2018

Online ‘Personal Health’ Campaign Aims to Educate and Empower People with Lung Diseases

News

Mediaplanet, a content marketing company, recently launched a “Personal Health” campaign that helps to raise awareness of different forms of lung disease, from pulmonary fibrosis and cancer to asthma ... Read more

June 5, 2018June 5, 2018

Second Opinion Option for IPF and Other Rare Disease Patients Now Part of Express Scripts and PinnacleCare Services

News

A Rare Conditions Care Value (RCCV) program providing access to “second opinions” for patients with rare diseases like idiopathic pulmonary fibrosis (IPF) was recently launched by two U.S. health ... Read more

June 4, 2018June 4, 2018

France Foundation-Genentech Initiative to Improve IPF Diagnosis, Treatment at Local Level

Esbriet, News

Supported by an educational research grant from Genentech, the France Foundation is launching a mentoring and relationship-building program for community healthcare providers to improve how patients with idiopathic pulmonary fibrosis ... Read more

May 18, 2018May 18, 2018

Pulmonary Fibrosis Foundation Adds 15 Treatment Sites to Its Care Center Network

News

The Pulmonary Fibrosis Foundation (PFF) has added 15 treatment sites to its nationwide Care Center Network (CCN) — including one each in Wisconsin and Iowa, states which previously did not ... Read more

April 26, 2018April 26, 2018

Digital Health Company patientMpower Launches New Lung Transplant App

News

The digital healthcare company patientMpower recently released a new platform called patientMpower for Lung Transplant for patients with pulmonary fibrosis (PF) and other conditions who have received a lung transplant. In January, patientMpower was ... Read more

April 19, 2018April 19, 2018

BerGenBio Therapy Reins in Lung and Liver Tissue Scarring, Research Shows

News

BerGenBio’s bemcentinib (BGB324) stops the progression of aggressive tissue scarring in the lungs and liver, preclinical-trial research shows. Researchers published the findings in the American Journal of Respiratory and Critical Care Medicine. The ... Read more

April 13, 2018April 13, 2018

Reviva’s Investigational Therapy RP5063 Receives FDA Orphan Drug Status for IPF Treatment

News

The U.S. Food and Drug Administration recently granted orphan drug status to Reviva Pharmaceuticals’ treatment candidate RP5063 for idiopathic pulmonary fibrosis (IPF). Reviva is now planning to launch Phase ... Read more

April 6, 2018April 6, 2018

Boehringer Ingelheim and Minor League Baseball to Partner on Raising Awareness of IPF

News

Boehringer Ingelheim’s signature Breathless Campaign will collaborate with Minor League Baseball this season to raise awareness of idiopathic pulmonary fibrosis (IPF). The baseball league has named Boehringer Ingelheim an official IPF ... Read more

March 27, 2018March 27, 2018

Broadway Belts Fund-raiser Generates Record $350,000 to Fight Pulmonary Fibrosis

News

The Pulmonary Fibrosis Foundation’s annual Broadway Belts for PFF! fund-raiser generated a record $350,000 this year. This brought the amount raised in the event’s eight years to nearly $1.2 million. The proceeds ... Read more

March 15, 2018March 15, 2018

HGE Health Extends Telemedicine Service to Pulmonary Fibrosis Patients

News

HGE Health of Philadelphia is partnering with the Temple Lung Center to offer a telemedicine disease management program for idiopathic pulmonary fibrosis (IPF) patients in the United States and elsewhere. The healthcare technology company ... Read more